Empty Capsules Market to 2030 - Size, Share, Growth & Trends
分析师观点：
该报告包括由于当前空胶囊市场趋势及其在预测期内可预见的影响而产生的增长前景。促进市场增长的主要因素包括老年人口的增加；制药、营养品和化妆品行业对空胶囊的需求增加；消费者对胶囊的偏好超过了片剂。患有各种慢性疾病的老年人群是药品制造商的主要目标。与片剂/丸剂相比，老年人主要更喜欢胶囊，因为它们易于吞咽、溶解更快并减少胃肠道刺激。然而，原材料价格上涨以及与用于生产胶囊的材料（特别是来自动物的非活性成分）相关的文化和宗教问题阻碍了空胶囊市场的增长。原材料的可及性有限、明胶制造商严格的监管制度以及种族和饮食限制也阻碍了市场的增长。
市场概述：
推动空心胶囊市场增长的关键因素包括与其他胶囊相比，胶囊的接受度不断提高药物输送形式以及空胶囊供应商和明胶制造商之间的战略合作。此外，研发活动和临床试验的激增、新产品的推出和关键开发以及胶囊输送技术的快速进步预计将对未来几年的空心胶囊市场预测产生重大影响。例如，2019 年 11 月，Qualicaps, Inc. 在 CPHI WORLDWIDE 2019 会议上推出了硬胶囊剂型。
市场驱动力：
蓬勃发展的保健品和膳食补充剂行业推动市场增长
根据一项题为“营养保健品关系：在一个地方揭开完整营养解决方案”的研究报告，2021 年全球营养保健品市场规模估值为 4545.5 亿美元，预计从 2021 年到 2030 年复合年增长率将增长 9.0%。此外，根据美国国际贸易管理局的数据，到 2023 年，印度预计将占全球营养保健品行业价值的 3.5% 左右；印度的营养保健品行业预计将从 2020 年的约 40 亿美元增长到 2025 年底的 180 亿美元。营养保健品和补充剂行业提供维生素、矿物质、草药提取物、益生菌和其他生物活性化合物。这些物质通常需要封装以方便食用。空胶囊为此类成分提供了高效且多功能的输送系统，使制造商能够生产多样化的产品。空胶囊允许制造商根据特定成分、剂量和目标群体定制配方。这种灵活性对于营养保健品和膳食补充剂行业至关重要，因为不同的产品需要不同的剂量和成分组合。因此，填充营养保健品或膳食补充剂的胶囊可帮助制造商满足消费者在质量、便利性和有效性方面的期望，这是推动空胶囊需求的主要因素。
细分分析：
空胶囊市场分析已通过考虑以下细分市场进行：产品、功能、应用和最终用户。
根据产品，空心胶囊市场分为明胶胶囊和非明胶胶囊。明胶胶囊细分市场将在 2022 年占据更大的市场份额。预计非明胶胶囊细分市场在 2022 年至 2030 年期间的复合年增长率将达到 9.0%。明胶在胶囊制造商中的普及归因于明胶胶囊能够实现药物快速释放和均匀药物混合，从而防止药物分子氧化。然而，对动物产品过敏的日益担忧也刺激了对无明胶/非明胶胶囊的需求。此外，越来越多的素食主义者和素食主义者更喜欢植物性替代品。因此，预计该细分市场的市场在未来几年将以更快的速度增长。
空心胶囊市场根据功能分为速释胶囊、缓释胶囊和缓释胶囊。释放胶囊。速释胶囊细分市场在 2022 年占据最大的市场份额。预计在预测期内复合年增长率将达到 8.5% 的最高复合年增长率。抗酸剂和抗菌抗生素生产和包装设施对速释胶囊的需求很高。根据 Nitta Gelatin India 于 2022 年 6 月发表的一篇文章，速释胶囊填充剂最常用于治疗各种常见疾病和病症。
空胶囊市场根据应用分为抗生素和抗菌药物药物、维生素和膳食补充剂、抗酸剂和抗胀气制剂等。抗生素和抗菌药物领域在 2022 年占据最大的空胶囊市场份额。维生素和膳食补充剂领域的市场预计在 2022 年至 2030 年期间将以 8.9% 的最快复合年增长率增长。抗生素和抗菌药物用于预防或治疗某些微生物感染。传染病病例的增加、低收入和中等收入国家对抗生素的需求不断增长以及主要制药公司研发投资的激增是支撑抗生素和抗菌制造和包装设施对空胶囊需求的关键因素。维生素和补充剂领域的增长归因于全球老年人口的增长和对治疗药物的需求不断增加，以及为了更好的健康结果而营养补充剂的日益普及。
根据最终用户，空胶囊市场分为两部分进入制药行业、营养保健品行业、化妆品行业和研究实验室。 2022 年，制药行业占据了最大的空胶囊市场份额，预计 2022 年至 2030 年复合年增长率最高，为 8.4%。由于改善适口性和更快吸收等多种动机，胶囊是最常见的固体剂型。这些空胶囊满足制药行业治疗各种慢性和传染病的最高需求。此外，随着研发、临床研究活动和胶囊给药技术发展的增加，制药行业也取得了进步。因此，随着人们对药物的需求不断增长，制药行业的扩张预计将在预测期内支持该领域的市场增长。
区域分析：
空心胶囊市场报告的范围包括北方美洲、欧洲、亚太地区、中东和非洲、以及南美洲和中美洲。 2022年北美市场估值为18.3亿美元，预计到2030年将达到34.5亿美元；预计 2022 年至 2030 年复合年增长率为 8.3%。北美空胶囊市场分为美国、加拿大和墨西哥。北美市场的增长归因于人们对胶囊营养保健品配方的日益青睐，这种配方有助于预防癌症、肥胖和关节炎等严重的健康问题。慢性病和老年人常见疾病的病例不断增加，尤其是在美国，也可能与该地区的市场增长有关。根据人口资料局的人口公报：美国的老龄化，预计 65 岁及以上的美国人数量将从 2018 年的 5200 万增加近一倍，达到 2060 年的 9500 万。美国和加拿大拥有发达、结构化的医疗保健系统鼓励全球市场公司进入这些国家。因此，这些国家拥有众多的全球市场参与者。该地区的全球参与者满足了对空心胶囊的高需求。
欧洲占空心胶囊市场的第三大份额。该地区的市场增长归因于疾病患病率的增加和药物的高可及性以及研发的热潮。英国在欧洲空心胶囊市场占有最大份额。此外，预计德国市场在预测期内将以最快的复合年增长率增长。
亚太地区预计将在 2022 年至 2030 年期间成为全球空胶囊市场最高的复合年增长率。该地区的市场增长归因于可支配收入的激增和对营养补充剂的偏好。由于气候条件的变化和工作人口的增长，人们对护肤的意识越来越强，HPMC空胶囊被用来封装精油、维生素和抗氧化剂等有效成分，从而促进了该地区空胶囊行业的增长。据印度品牌股权基金称，印度美容和个人护理市场规模从 2019 年的 99.8 亿美元增至 2021 年的 151 亿美元。因此，不断增长的化妆品和制药行业，尤其是韩国、印度、日本，和中国，预计将在预测期内促进亚太地区空胶囊市场的增长。
主要参与者分析：
Erawat Pharma Limited、Sunil Healthcare、ACG Worldwide、Medi-Caps Ltd、 LonzaGroup (Capsugel)、Capscanada Corporation、Bright Pharma Caps Inc、Farmacapsulas、三菱化学控股公司 (Qualicaps, Inc.) 和 Roxlor LLC 是空心胶囊市场报告中介绍的主要参与者。
最新动态：
在市场上经营的公司采取并购等方式。以下列出了近期的一些市场动态：
2023 年 3 月，ACG 公司 VANTAGE NUTRITION 收购了 ComboCap, Inc.（美国）和 BioCap（南非），以扩大其在北美和全球的技术和足迹。
2022年1月，西安乐纽特拉配料股份有限公司向欧洲拉脱维亚发运800万粒HPMC胶囊。这些胶囊不含二氧化钛 (TiO2)，因为欧盟委员会已禁止在食品添加剂中使用二氧化钛。这凸显了该公司为满足该地区产品需求所做的努力。
2022 年 7 月，Akums Drug & Pharmaceuticals Ltd. 批准了其位于印度哈里瓦的空硬明胶胶囊生产设施。这家总部位于欧盟（EU-based）的公司以采用良好生产规范（GMP）而闻名。
2022 年 2 月，Lyfe 集团旗下公司 CapsCanada 的液体填充阿司匹林胶囊获得批准。该产品基于PLxGuard药物输送平台，旨在将药物输送到胃肠道的目标区域。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global empty capsules market, based on product is segmented into gelatin capsules and non-gelatin capsules. The gelatin capsules segment held a larger market share in 2022. The non-gelatin capsules segment is estimated to register a higher CAGR of 9.0% during 2022–2030. Based on functionality, the market is segmented into immediate-release capsules, delayed-release capsules, and sustained-release capsules. The immediate-release capsules segment held the largest market share in 2022. It is further expected to register the highest CAGR of 8.5% during the forecast period. Based on application, the empty capsules market is segmented into antibiotics and antibacterial drugs, vitamins and dietary supplements, antacids and antiflatulent preparations, and others. The antibiotics and antibacterial drugs segment held the largest empty capsules market share in 2022. The market for the vitamins and dietary supplements segment is expected to grow at the fastest CAGR of 8.9% during 2022–2030. In terms of end user, the empty capsules market is segmented into pharmaceutical industry, nutraceutical industry, cosmetics industry, and research laboratories. The pharmaceutical industry segment held the largest empty capsules market share in 2022 and the same is anticipated to register the highest CAGR of 8.4% during 2022–2030.
Empty capsules are made of gelatin, hydroxypropyl methylcellulose (HPMC), pullulan, and starch. These capsules can also be used to fill formulations that are used to treat acute and chronic diseases, cancer, and common diseases such as cold and cough. They are also used to package nutritional supplement formulations, antacid and anti-flatulence medications, and personalized medicines.
The factors driving the growth of the empty capsules market include the flourishing nutraceutical and dietary supplement industries and continuously growing pharmaceuticals industry.
The empty capsules market majorly consists of the players such as Erawat Pharma Limited, Sunil Healthcare, ACG Worldwide, Medi-Caps Ltd, LonzaGroup (Capsugel), Capscanada Corporation, Bright Pharma Caps Inc, Farmacapsulas, Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.), and Roxlor LLC.
The empty capsules market was valued at US$ 6.7 billion in 2022.
The empty capsules market is expected to be valued at US$ 12.5 billion in 2030.
The List of Companies - Empty Capsules Market
- Erawat Pharma Limited
- Sunil Healthcare
- ACG Worldwide
- Medi-Caps Ltd
- LonzaGroup (Capsugel)
- Capscanada Corporation
- Bright Pharma Caps Inc
- Farmacapsulas
- Mitsubishi Chemical Holdings Corporation (Qualicaps, Inc.)
- Roxlor LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For